"Perimenopause" is used loosely to describe the years before menopause, but the term covers a span of biological change more varied than a single phase suggests. For many women, the most disruptive changes begin years before their cycles show any irregularity, and the symptoms shift in character as the transition progresses.

Researchers have developed a formal staging system to map these changes precisely. It helps explain why symptoms at 43 can feel entirely different from symptoms at 50, even though both fall under the broad label of perimenopause.

The STRAW+10 Staging System

The Stages of Reproductive Aging Workshop plus 10 (STRAW+10) is the gold standard framework for classifying where a woman is in her reproductive lifespan.[1] First published in 2001 and revised in 2011 after a decade of validation data, it is the reference clinicians and researchers use to define staging in studies and to guide decisions about when to investigate symptoms and when to consider treatment.

STRAW+10 divides the female reproductive lifespan into three broad categories: reproductive years, the menopausal transition, and postmenopause. These subdivide into ten numbered stages running from Stage -5 (peak reproductive years) through Stage +2 (late postmenopause). Staging is based primarily on menstrual cycle patterns, supported by hormone measurements.[1]

The Late Reproductive Stage: Before Cycles Change

The process begins earlier than most women expect. Stage -3b is characterised by regular cycles alongside the earliest detectable hormonal shifts: subtle rises in FSH (follicle-stimulating hormone) during the early follicular phase.[2]

Most women at this stage have no symptoms, or none at all. Premenstrual symptoms that were not previously prominent may intensify, and cycles may shorten by a day or two, nothing that registers as irregular on a period tracking app. Yet biologically, the ovaries are already beginning to respond differently to hormonal signals, a process that can begin as early as the late 30s, with genetic and lifestyle factors affecting exactly when.

Early Perimenopause: Cycles Become Variable

Stage -2, the early menopausal transition, is defined by a persistent change in cycle length of seven or more days from the woman's typical pattern.[1] A cycle that ran 28-30 days might now vary between 22 and 38 days. This variability reflects increasingly unpredictable follicular development as ovarian reserve diminishes.

FSH elevation is variable at this stage (high one month, normal the next), which is why a single FSH blood test is not a reliable diagnostic tool here. Estrogen levels are not consistently low; they are volatile, sometimes surging above previous baseline before crashing. This volatility, not simple estrogen deficiency, drives many of the symptoms of early perimenopause.[2]

Vasomotor symptoms (hot flashes, night sweats) can begin during the early transition, often beginning in the years before the final menstrual period, though individual variation is wide.[3] Sleep disruption, mood changes, and cognitive complaints often appear at this stage, partly from hormonal volatility and partly from sleep fragmentation.

Late Perimenopause: Gaps Between Cycles Lengthen

Stage -1, the late menopausal transition, begins when a woman has her first gap in bleeding of 60 days or more. It typically spans one to three years before the final menstrual period.[1]

During this stage FSH levels rise more consistently, generally above 25 IU/L (though thresholds vary by assay and individual), and estradiol begins to decline more reliably rather than fluctuating erratically. Vasomotor symptoms often intensify. Bone density loss, previously limited by estrogen's protective effect, begins to accelerate.[2]

For many women, the late perimenopause is the most symptomatic period of the entire transition, more so than the postmenopausal years that follow.

Menopause Is a Single Point, Not a Phase

Menopause is defined as exactly twelve consecutive months without a menstrual period, with no other cause.[1] It is not a phase or a transition; it is a single point in time, confirmed retrospectively. The date of the final menstrual period is designated Stage 0.

Because it is confirmed only in hindsight, women cannot know they have reached menopause until a year after their last period. Average age at natural menopause in Western populations is around 51, with a normal range of roughly 45-55 years.[3]

Early Postmenopause

The two to three years following menopause (Stage +1) are the early postmenopause. FSH continues to rise and estradiol reaches its new stable low. Vasomotor symptoms frequently remain most severe during this period.

Stage +1 is also when hormonal treatment tends to show the greatest benefit. The "critical window hypothesis" (supported by observational and reanalysis data, though still an area of active debate) refers to starting treatment during or shortly after this transition, before extended estrogen deprivation leads to structural changes in blood vessels and other tissues.[3]

How Symptoms Map to Stages

The pattern of symptoms shifts across stages in ways that reflect the underlying biology.

During early perimenopause, estrogen volatility (up, down, unpredictable) tends to drive anxiety, mood instability, and sleep disruption. Many women notice they are responding to stress differently, or that their emotional baseline has shifted, before they would describe themselves as having hot flashes.

During late perimenopause, as estrogen trends downward more consistently, vasomotor symptoms often peak, genitourinary changes begin, and cognitive symptoms from cumulative sleep deprivation accumulate.

In postmenopause, vasomotor symptoms ease for many women over two to five years. Genitourinary symptoms, by contrast, continue to progress without treatment.

Staging in Clinical Conversations

If your cycles are variable but vasomotor symptoms haven't started, the data suggests hot flashes are likely within the next two to four years. If you are already in the late transition, you are probably within three years of your final period.

It affects which symptoms are expected, which investigations are appropriate, and which treatment approaches are most likely to help at that point in the transition. If your cycles have become shorter than 21 days, you have experienced amenorrhea before age 45, or you have any concern about premature ovarian insufficiency, these warrant prompt clinical assessment rather than watchful waiting.

References

[1] Harlow, S. D., Gass, M., Hall, J. E., et al. (2012). Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging. Menopause, 19(4), 387-395. https://pmc.ncbi.nlm.nih.gov/articles/PMC3340903/

[2] Randolph, J. F., Zheng, H., Sowers, M. R., et al. (2011). Change in follicle-stimulating hormone and estradiol across the menopausal transition: Effect of age at the final menstrual period. Journal of Clinical Endocrinology & Metabolism, 96(3), 746-754. https://pmc.ncbi.nlm.nih.gov/articles/PMC3823936/

[3] Santoro, N., Epperson, C. N., Mathews, S. B. (2015). Menopausal symptoms and their management. Endocrinology and Metabolism Clinics of North America, 44(3), 497-515. https://www.ncbi.nlm.nih.gov/books/NBK507826/